Clinical Trial Update: A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study update evaluating weight management with LY3841136 and tirzepatide (LY3298176), alone or in combination, in adults with obesity or overweight an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LY3841136
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 2 | Status: ACTIVE_NOT_RECRUITING